Practice of clinical application of noninvasive prenatal testing based on cell-free fetal DNA.
10.3760/cma.j.cn511374-20211110-00893
- Author:
Honglei DUAN
1
;
Wanjun WANG
;
Ying ZHANG
;
Wei LIU
;
Leilei GU
;
Jie LI
Author Information
1. Center of Prenatal Diagnosis, Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu 210008, China. jie1967@126.com.
- Publication Type:Journal Article
- MeSH:
Aneuploidy;
Cell-Free Nucleic Acids/genetics*;
DNA/genetics*;
DNA Copy Number Variations;
Female;
Fetus;
Humans;
Noninvasive Prenatal Testing;
Pregnancy;
Retrospective Studies
- From:
Chinese Journal of Medical Genetics
2022;39(3):264-268
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the application value of noninvasive prenatal testing (NIPT) based on cell-free fetal DNA.
METHODS:The results of 2777 cases of basic and extended NIPT were retrospectively analyzed. The clinical data and outcome of pregnancy were analyzed, in addition with the diagnosis rate and testing efficiency.
RESULTS:Among the 2777 pregnant women, 1192 (42.9%) had accepted basic NIPT and 1585 (57.1%) accepted extended NIPT. With a failure rate of 0.1%, 8 and 6 cases were reported respectively as high-risk pregnancies for trisomy 21 and sex chromosomal abnormalities. Other genetic abnormalities were detected in 32 cases. The positive predictive value for trisomy 21 was 85.7%, and one case of 47,XXX was diagnosed among 3 women with high risks for sex chromosomal abnormalities. For those with a high risk for other genetic abnormalities, pregnant diagnosis rates of basic and extended NIPT were 71.4% (5/7) and 68.2% (15/22), respectively. Seven copy number variations (CNVs) were confirmed, including one pathogenic CNV, one likely pathogenic CNV and 5 variants of unknown significance. Among 6 cases with high-risk of maternal CNVs, 5 fetuses and the mothers were confirmed to be carriers. No CNV was detected in the remainder fetus by chromosomal microarray analysis, while its mother was a carrier of the corresponding CNV.
CONCLUSION:NIPT has shown a relatively high positive predictive value for the screening of trisomy 21 and maternal CNVs but with a limited efficiency for the discovery of fetal CNVs. For other genetic abnormalities signaled by NIPT, informed choice by the pregnant women during pre-testing consultation is recommended. Invasive prenatal diagnosis should be considered in the combination of NIPT reports and fetal ultrasound, while the residual risks should be fully informed.
